This is the authors' abstract. We don't add key points for this paper.
Introduction Arthritis and rheumatic conditions (i.e., arthritis) are responsible for major health care expenditures and disability burdens. The impact of arthritis is not restrained by national boundaries. It is one of the most prevalent chronic conditions and is a leading cause of disability in Australia (1), Canada (2,3), Europe (4), the United Kingdom (5), and the United States (6,7), affecting an estimated 3 million Australians, 6 million Canadians, 8 million in the UK, almost 43 million people in the US, and 103 million across Europe. With the aging of the baby boomers, these numbers and the associated disabilities will quickly escalate. By 2020 in the US alone, arthritis is projected to affect 60 million people, and the activities of 12 million people may be limited by arthritis (6). The growing magnitude of people affected by arthritis motivates the need to review what is known about its national costs to identify areas where current information is lacking. In addition, it is important to determine targets for public health efforts that will reduce the costs of and burden from arthritis. This knowledge will facilitate planning research agendas that support informed public policy decisions.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dunlop et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: